Pancreatobiliary disorder

1 paper1 finding

Humans1

Associations

1

Liraglutide

upin humans1HR 1.33

1 study

Liraglutide raises the risk of pancreatobiliary disorder in humans (HR 1.33, 95% CI 1.09-1.63).
“pancreatobiliary disorder (1.33, 1.09-1.63)”
Humansfor weight loss vs matched non-initiatorsn = 6,953
GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study
Diabetes, obesity & metabolism6 Jul 2026

More on Liraglutide

Latest

1 in 12 months

Diabetes, Obesity & Metabolism7 Jul

GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study

Cohort study of 68,001 peopleGLP-1 receptor agonists